These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14643836)

  • 21. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
    Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
    J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute performance-impairing and subject-rated effects of triazolam and temazepam, alone and in combination with ethanol, in humans.
    Simpson CA; Rush CR
    J Psychopharmacol; 2002 Mar; 16(1):23-34. PubMed ID: 11949768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
    Rush CR; Stoops WW; Hays LR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):261-71. PubMed ID: 18926645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users.
    Lile JA; Kelly TH; Hays LR
    Behav Pharmacol; 2010 Feb; 21(1):29-38. PubMed ID: 19949319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the acute behavioral effects of flunitrazepam and triazolam in healthy volunteers.
    Farré M; Terán MT; Camí J
    Psychopharmacology (Berl); 1996 May; 125(1):1-12. PubMed ID: 8724443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the acute behavioral effects of triazolam and temazepam in normal volunteers.
    Rush CR; Higgins ST; Hughes JR; Bickel WK
    Psychopharmacology (Berl); 1993; 112(4):407-14. PubMed ID: 7871050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alprazolam attenuates the behavioral effects of d-amphetamine in humans.
    Rush CR; Stoops WW; Wagner FP; Hays LR; Glaser PE
    J Clin Psychopharmacol; 2004 Aug; 24(4):410-20. PubMed ID: 15232333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization to the cardiovascular but not subject-rated effects of oral cocaine in humans.
    Kollins SH; Rush CR
    Biol Psychiatry; 2002 Jan; 51(2):143-50. PubMed ID: 11822993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital.
    Zawertailo LA; Busto UE; Kaplan HL; Greenblatt DJ; Sellers EM
    J Clin Psychopharmacol; 2003 Jun; 23(3):269-80. PubMed ID: 12826989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of the discriminative stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women.
    Babalonis S; Emurian CS; Martin CA; Lile JA; Kelly TH
    Drug Alcohol Depend; 2008 Apr; 94(1-3):276-80. PubMed ID: 18178039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of triazolam and ethanol on awareness, memory, and psychomotor performance.
    Roache JD; Cherek DR; Bennett RH; Schenkler JC; Cowan KA
    J Clin Psychopharmacol; 1993 Feb; 13(1):3-15. PubMed ID: 8486815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB.
    Carter LP; Richards BD; Mintzer MZ; Griffiths RR
    Neuropsychopharmacology; 2006 Nov; 31(11):2537-51. PubMed ID: 16880774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.
    Sevak RJ; Stoops WW; Hays LR; Rush CR
    J Pharmacol Exp Ther; 2009 Mar; 328(3):1007-18. PubMed ID: 19104030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminative-stimulus effects of modafinil in cocaine-trained humans.
    Rush CR; Kelly TH; Hays LR; Wooten AF
    Drug Alcohol Depend; 2002 Aug; 67(3):311-22. PubMed ID: 12127202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reinforcing effects of oral cocaine: contextual determinants.
    Jones HE; Garrett BE; Griffiths RR
    Psychopharmacology (Berl); 2001 Mar; 154(2):143-52. PubMed ID: 11314676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure.
    Oliveto AH; Bickel WK; Kamien JB; Hughes JR; Higgins ST
    Psychopharmacology (Berl); 1994 Apr; 114(3):417-23. PubMed ID: 7531852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute behavioral and cardiac effects of cocaine and alcohol combinations in humans.
    Higgins ST; Rush CR; Bickel WK; Hughes JR; Lynn M; Capeless MA
    Psychopharmacology (Berl); 1993; 111(3):285-94. PubMed ID: 7870965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans.
    Oliveto AH; Rosen MI; Woods SW; Kosten TR
    J Pharmacol Exp Ther; 1995 Jan; 272(1):231-41. PubMed ID: 7815337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users.
    Marks KR; Lile JA; Stoops WW; Rush CR
    Psychopharmacology (Berl); 2014 Jul; 231(14):2741-50. PubMed ID: 24464531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.